AIDS Walk San Francisco Only Weeks Away
<p>UCSF teams are working hard to achieve a collective fundraising goal of $55,000 in AIDS Walk San Francisco, which is on July 15.</p>
University of California San Francisco
Give to UCSF<p>UCSF teams are working hard to achieve a collective fundraising goal of $55,000 in AIDS Walk San Francisco, which is on July 15.</p>
An investigation led by UCSF has found that the risk of female-to-male HIV transmission is increased three fold for women with bacterial vaginosis, a common disorder in which the normal balance of bacteria in the vagina is disrupted.
After being infected with simian immunodeficiency virus (SIV) in a laboratory study, rhesus macaques that had more of a certain type of immune cell in their gut than others had much lower levels of the virus in their blood, and for six months after infection were better able to control the virus.
Warner Greene, MD, PhD, a UCSF professor of medicine who directs virology and immunology research at the Gladstone Institutes, has been inducted as president of the Association of American Physicians.
In a groundbreaking study published last year, scientists reported that effective treatment with HIV medications not only restores health and prolongs life in many HIV-infected patients, but also curtails transmission to sexual partners up to ninety-seven percent.
<p><em>Time </em>magazine has named Gladstone and UCSF scientist Robert Grant, MD, MPH, to the <a href="https://www.time.com/time/specials/packages/article/0,28804,2111975_2111976_2112159,00.html" target="_blank">2012 TIME 100</a>, the magazine’s annual list of the world’s 100 most influential people.</p>
<p>To effectively confront the HIV/AIDS epidemic in Oakland, the medical community needs to connect with African-American young men, who are a particularly vulnerable group of individuals who may not know they are at high risk and may not be receiving the information they need to protect themselves.</p>
Physical violence, sexual abuse and other forms of childhood and adult trauma are major factors fueling the epidemic of HIV/AIDS among American women, who account for at least 27 percent of new U.S. cases.
President Barack Obama appointed UCSF AIDS expert Grant Colfax, MD, as the director of the Office of National AIDS Policy.
A drug once taken by people with HIV/AIDS, but long ago shelved after newer, modern antiretroviral therapies became available, has now shed light on how the human body uses its natural immunity to fight the virus — work that could help uncover new targets for drugs.
<p>Paul Volberding, MD, one of the world's leading experts on treatment for patients infected with HIV, the AIDS virus, became the new director of the AIDS Research Institute (ARI) at UCSF on Feb. 13.</p>
<p>Scientists at the San Francisco VA Medical Center and the University of California, San Francisco have published a study showing that one of the most effective and commonly prescribed antiretroviral medications for HIV/AIDS, tenofovir, is associated with a significant risk of kidney damage and chronic kidney disease that increases over time. See accompanying news release, <a href="http://ucsf.edu/news/2012/02/11508/tenofovir-leading-hiv-medication-linked-risk-kidney-damage">Tenofovir, Leading HIV Medication, Linked with Risk of Kidney Damage</a>.</p>